Henry Schein Inc. (HSIC) shares plummeted 5.01% in intraday trading on Tuesday, February 25th, following the company's disappointing fourth-quarter earnings results and weak guidance for 2025, reflecting the impact of persistent inflation and tepid demand for dental products.
The medical and dental products distributor reported adjusted earnings per share (EPS) of $1.19 for the fourth quarter, missing analyst estimates of $1.21. Revenue for the quarter came in at $3.19 billion, falling short of the expected $3.27 billion, as higher prices squeezed customer budgets, forcing them to cancel or postpone non-urgent procedures.
For the full year 2025, Henry Schein forecasted adjusted EPS in the range of $4.80 to $4.94, below Wall Street's estimates of $4.99. The company also expects annual sales growth of only 2% to 4%, lower than the projected $13.19 billion, citing tepid demand amid persistent inflation in the dental and medical end-markets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.